Biotech ends summer on a high

Biotech finished on a high in August, according to San Francisco venture capital firm Burrill & Company.

The company’s Burrill Biotech Select Index closed up 4.4 percent on Friday before the Labor Day holiday weekend, said G. Steven Burrill, company CEO.

Top performers included Emeryville’s Onyx Pharmaceuticals (ONXX), up 42 percent, and Vertex Pharmaceuticals, up 21 percent.

Bay Area pot shops face mob robberies — get little help

‘It’s proving to be unbearable for cannabis operators’

By Veronica Irwin
Supes vs. mayor: Fight breaks out on how to spend Prop I money

Board approves $64 million to acquire small apartment buildings against Breed’s wishes

By Benjamin Schneider
Letterform Archive reopens with major Bauhaus exhibition

Revolutionary art school’s legacy: To show design is the world we live in

By Max Blue Special to The Examiner